Tissue Predictors of Abiraterone Benefit

Clinical trial NCT03176381 · COMPLETED

Trial details

NCT number: NCT03176381
Sponsor: Tianjin Medical University Second Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2017-05-05
Primary completion: 2023-05-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.